295 related articles for article (PubMed ID: 23627905)
1. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
[TBL] [Abstract][Full Text] [Related]
2. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
3. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
Mahrooz A; Zargari M; Sedighi O; Shaygani H; Gohari G
Clin Invest Med; 2012 Jun; 35(3):E144-51. PubMed ID: 22673317
[TBL] [Abstract][Full Text] [Related]
4. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis.
El-Saeed GS; Fadel F; Elshamaa MF; Galal RE; Elghoroury EA; Nasr SA; Thabet EH; Abdelrahman SM
Ren Fail; 2015; 37(9):1452-6. PubMed ID: 26337710
[TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
7. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis.
Gritters M; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Scheffer PG; Teerlink T; Schalkwijk CG; Spreeuwenberg M; Nubé MJ
Nephrol Dial Transplant; 2006 Jan; 21(1):153-9. PubMed ID: 16144857
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
[TBL] [Abstract][Full Text] [Related]
9. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Zoga M; Alevyzaki F; Stamatelou K; Frangou E; Savva L; Nicolaou C
Nephrology (Carlton); 2006 Dec; 11(6):506-9. PubMed ID: 17199788
[TBL] [Abstract][Full Text] [Related]
10. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
[TBL] [Abstract][Full Text] [Related]
11. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
[TBL] [Abstract][Full Text] [Related]
12. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
Baldi S; Innocenti M; Frascerra S; Nannipieri M; Lippi A; Rindi P; Ferrannini E
J Nephrol; 2013; 26(3):549-55. PubMed ID: 22941872
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of plasma myeloperoxidase in ESRD patients.
Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
Am J Kidney Dis; 2010 Nov; 56(5):937-46. PubMed ID: 20638167
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
15. The relationship between concentrations of magnesium and oxidized low-density lipoprotein and Beta2-microglobulin in the serum of patients on the end-stage of renal disease.
Raikou VD; Kyriaki D
Saudi J Kidney Dis Transpl; 2016 May; 27(3):546-52. PubMed ID: 27215248
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
[TBL] [Abstract][Full Text] [Related]
17. Correlation between oxidized low-density lipoprotein and other factors in patients on peritoneal dialysis.
Futatsuyama M; Oiwa T; Komatsu Y
Adv Perit Dial; 2002; 18():192-4. PubMed ID: 12402617
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy.
Diepeveen SH; Verhoeven GH; van der Palen J; Dikkeschei BL; van Tits LJ; Kolsters G; Offerman JJ; Bilo HJ; Stalenhoef AF
Nephron Clin Pract; 2004; 98(1):c3-7. PubMed ID: 15361698
[TBL] [Abstract][Full Text] [Related]
20. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality.
Lobo JC; Stockler-Pinto MB; Farage NE; Faulin Tdo E; Abdalla DS; Torres JP; Velarde LG; Mafra D
Ren Fail; 2013; 35(5):680-5. PubMed ID: 23650973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
